Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis

NCT00037700 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: anakinra
DRUG: pegsunercept

Sponsor

Amgen